Milan, Italy - Promising 6-month results of one of the first clinical studies of a drug-eluting stent for in-stent restenosis (ISR) were not maintained at 12 months and carry an important message for ...
For coronary in-stent restenosis (ISR), drug-coated balloons (DCB) appear to perform just as well over the long term as thin-strut drug-eluting stents after accounting for differences in patient ...
San Francisco, CA—Two presentations at TCT 2013 addressed the increasing body of evidence supporting the use of drug-coated balloons (DCBs) as treatment for in-stent restenosis. Pierfrancesco Agostoni ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback